Nothing really unexpected here with growth continuing for 23rd consecutive quarter. With the expected R&D cash they will get in Q1 19 they should not need to raise again for at least 12 months and maybe never if they decide run for cash generation rather than growth.
About the only thing that is negative is the slight decline in the old market (USA, Australia, UK) on what we can assume is a major cutback in advertising (4400 rides by my calculations). The positive side to all this is the huge leap in gross profitability after paid acquisition costs, which went from -$50K last quarter to almost $500K this quarter.
- Forums
- ASX - By Stock
- JAY
- Ann: Quarterly Business Review and Appendix 4C
Ann: Quarterly Business Review and Appendix 4C, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAY (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.907M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.8¢ | $802 | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23027 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 310022 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23027 | 0.008 |
4 | 1248710 | 0.007 |
2 | 1250000 | 0.006 |
1 | 300000 | 0.005 |
2 | 750248 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 310022 | 1 |
0.011 | 5000 | 1 |
0.014 | 52603 | 1 |
0.015 | 308978 | 1 |
0.016 | 258535 | 1 |
Last trade - 12.49pm 21/10/2024 (20 minute delay) ? |
Featured News
JAY (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online